Behavioral processes mediating phencyclidine-induced decreases in voluntary sucrose consumption
- PMID: 17904209
- PMCID: PMC2266588
- DOI: 10.1016/j.pbb.2007.08.011
Behavioral processes mediating phencyclidine-induced decreases in voluntary sucrose consumption
Abstract
Prior exposure to phencyclidine (PCP) has been shown to decrease voluntary sucrose consumption in rats, which may indicate reduced reward function. To further characterize the effects of PCP on sucrose consumption, we examined the dose-response relationship between PCP and sucrose consumption, the longevity of the effect, the effects of repeated injections of PCP, variation of the PCP effect across sucrose concentrations, and the effects of PCP on gustatory hedonic responses. A single injection of PCP (2.5-20 mg/kg) dose-dependently suppressed sucrose consumption 20 h post-injection, with significant decreases after 15 and 20 mg/kg PCP. These decreases were sustained three days following withdrawal from PCP. Repeated injections of PCP (7.5 mg/kg bid for 7 days) decreased sucrose consumption 20 h after withdrawal, which returned to baseline on the second day. A single injection of PCP (15 mg/kg) suppressed 0.15 M sucrose more than 1 M sucrose consumption, with no effect on 0.3 M sucrose, suggesting that PCP suppressed intake of moderately rewarding taste stimuli. Finally, a single injection of PCP (15 mg/kg) suppressed brief access (20 s) licking for the majority of concentrations of sucrose solutions offered (0.031 M, 0.062 M, 0.125 M, 0.25 M, 0.5 M, and 1.0 M), while it had no effect on licking for 0.016 M sucrose, water, or for bitter quinine hydrochloride solutions (range: 0.94 mM-30 mM), suggesting that the PCP effect is specific to palatable taste stimuli without disruption of sensitivity to taste quality or intensity. We conclude that PCP produces moderate anhedonia as reflected through a specific decrease in the sustained consumption of moderately palatable sucrose solutions.
Figures






Similar articles
-
Analysis of licking microstructure provides no evidence for a reduction in reward value following acute or sub-chronic phencyclidine administration.Psychopharmacology (Berl). 2010 Apr;209(2):153-62. doi: 10.1007/s00213-010-1779-x. Epub 2010 Feb 10. Psychopharmacology (Berl). 2010. PMID: 20145910
-
Prior exposure to phencyclidine decreases voluntary sucrose consumption and operant performance for food reward.Pharmacol Biochem Behav. 2003 Dec;76(3-4):393-400. doi: 10.1016/j.pbb.2003.08.019. Pharmacol Biochem Behav. 2003. PMID: 14643837
-
Differential effects of acute and subchronic clozapine and haloperidol on phencyclidine-induced decreases in voluntary sucrose consumption in rats.Pharmacol Biochem Behav. 2007 Mar;86(3):524-30. doi: 10.1016/j.pbb.2007.01.014. Epub 2007 Jan 23. Pharmacol Biochem Behav. 2007. PMID: 17320157
-
Anatomical dissociation of melanocortin receptor agonist effects on taste- and gut-sensitive feeding processes.Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R1044-56. doi: 10.1152/ajpregu.00577.2010. Epub 2011 Jul 6. Am J Physiol Regul Integr Comp Physiol. 2011. PMID: 21734020 Free PMC article.
-
Neuronal mechanisms of phencyclidine-induced place aversion and preference in the conditioned place preference task.Methods Find Exp Clin Pharmacol. 1998 Sep;20(7):607-11. doi: 10.1358/mf.1998.20.7.485726. Methods Find Exp Clin Pharmacol. 1998. PMID: 9819806 Review.
Cited by
-
Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.J Psychopharmacol. 2015 Apr;29(4):390-400. doi: 10.1177/0269881114565937. Epub 2015 Jan 13. J Psychopharmacol. 2015. PMID: 25586399 Free PMC article.
-
Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia.Eur Neuropsychopharmacol. 2014 May;24(5):744-58. doi: 10.1016/j.euroneuro.2013.10.001. Epub 2013 Oct 14. Eur Neuropsychopharmacol. 2014. PMID: 24183826 Free PMC article. Review.
-
Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.Schizophr Bull. 2010 Mar;36(2):271-88. doi: 10.1093/schbul/sbp125. Epub 2009 Nov 24. Schizophr Bull. 2010. PMID: 19934211 Free PMC article.
-
The hippocampo-prefrontal pathway: a possible therapeutic target for negative and cognitive symptoms of schizophrenia.Future Neurol. 2015;10(2):115-128. doi: 10.2217/FNL.14.63. Future Neurol. 2015. PMID: 25825588 Free PMC article.
-
Analysis of licking microstructure provides no evidence for a reduction in reward value following acute or sub-chronic phencyclidine administration.Psychopharmacology (Berl). 2010 Apr;209(2):153-62. doi: 10.1007/s00213-010-1779-x. Epub 2010 Feb 10. Psychopharmacology (Berl). 2010. PMID: 20145910
References
-
- Allen RM, Young SJ. Phencyclidine-induced psychosis. Am J Psychiatry. 1978;135(9):1081–4. - PubMed
-
- Baird JP, Rios C, Gray NE, Walsh CE, Fischer SG, Pecora AL. Effects of melanin-concentrating hormone on licking microstructure and brief-access taste responses. Am J Physiol Regul Integr Comp Physiol. 2006;291(5):R1265–74. - PubMed
-
- Baird JP, John SJ, Nguyen EA. Temporal and qualitative dynamics of conditioned taste aversion processing: combined generalization testing and licking microstructure analysis. Behav Neurosci. 2005;119(4):983–1003. - PubMed
-
- Bakker CB, Amini FB. Observations on the psychotomimetic effects of Sernyl. Compr Psychiatry. 1961;2:269–80. - PubMed
-
- Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 1998;28(3):309–69. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources